Page last updated: 2024-10-30

lobenzarit and Carditis

lobenzarit has been researched along with Carditis in 3 studies

lobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpd

Research Excerpts

ExcerptRelevanceReference
"The aim was to test the efficacy of the immune system modulator lobenzarit disodium in the treatment of coxsackievirus B3 myocarditis."7.68Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993)
"The aim of this study is to test the therapeutic efficacy of immunomodulation with lobenzarit disodium (CCA) upon coxsackievirus B3 (CB3) myocarditis."7.68The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993)
"Lobenzarit (CCA) is a newly developed immunomodulating drug that has been demonstrated to enhance suppressor T-cell number and function."5.28Effects of lobenzarit on murine acute viral myocarditis. ( Kanda, T; Murata, K; Suzuki, T; Yokoyama, T, 1992)
"The aim was to test the efficacy of the immune system modulator lobenzarit disodium in the treatment of coxsackievirus B3 myocarditis."3.68Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993)
"The aim of this study is to test the therapeutic efficacy of immunomodulation with lobenzarit disodium (CCA) upon coxsackievirus B3 (CB3) myocarditis."3.68The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993)
"Lobenzarit (CCA) is a newly developed immunomodulating drug that has been demonstrated to enhance suppressor T-cell number and function."1.28Effects of lobenzarit on murine acute viral myocarditis. ( Kanda, T; Murata, K; Suzuki, T; Yokoyama, T, 1992)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kishimoto, C2
Takada, H2
Kuroki, Y2
Matsushita, I2
Hiraoka, Y2
Kurokawa, M2
Ochiai, H2
Sasayama, S2
Yokoyama, T1
Kanda, T1
Suzuki, T1
Murata, K1

Other Studies

3 other studies available for lobenzarit and Carditis

ArticleYear
Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
    Cardiovascular research, 1993, Volume: 27, Issue:2

    Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Immunosuppressive Agents; Male; Mice; Mice

1993
The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.
    Heart and vessels, 1993, Volume: 8, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Coxsackievirus Infections; Enterovirus B, Human;

1993
Effects of lobenzarit on murine acute viral myocarditis.
    Cardiovascular drugs and therapy, 1992, Volume: 6, Issue:4

    Topics: Adjuvants, Immunologic; Animals; Blood Cell Count; Encephalomyocarditis virus; Enterovirus Infection

1992